LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
44 hedge funds and large institutions have $86M invested in LogicBio Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$720K | |
| 2 | +$284K | |
| 3 | +$275K | |
| 4 |
FT
Fiduciary Trust
Boston,
Massachusetts
|
+$223K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$136K |
Top Sellers
| 1 | -$8.1M | |
| 2 | -$1.53M | |
| 3 | -$950K | |
| 4 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
-$211K |
| 5 |
JG
Jefferies Group
New York
|
-$115K |